O.S. Levin, A.Yu. Nikitina, A.I. Nebozhin
Vertebrogenic cervical radiculopathy: modern approaches to diagnosis and treatment
|
№1-2 / 2023
|
D.Yu. Andriyashkina, A.A. Klimenko, N.A. Demidova, A.A. Kondrashov, M.O. Anischenko
Delayed-release drugs for the treatment of knee osteoarthritis – drugs of choice in a comorbid patient
|
№1-2 / 2023
|
A.I. Listratov, T.M. Ostroumova, A.I. Kochetkov, O.D. Ostroumova, D.A. Sychev
Controversial and unresolved aspects of drug-induced hemorrhagic stroke: focus on selective serotonin reuptake inhibitors, non-steroidal anti-inflammatory drugs and statins
|
№13 / 2022
|
M.V. Leonova
Clinically significant drug interactions with warfarin: bleeding risk
|
№13 / 2022
|
G.B. Dikke
Primary dysmenorrhea. Dynamics of scientific views and women’s perception
|
№6 / 2022
|
D.I. Trukhan, D.S. Ivanova
Drug safety in real clinical practice: focus on protective therapy
|
№3 / 2022
|
I.G. Pakhomova (1), I.V. Gubonina (2)
NSAID-INDUCED PATHOLOGY OF THE GASTROINTESTINAL TRACT: WHAT IS REMAINING IN THE SHADOW?
|
№s5-17 / 2017
|
N.P. Lyamina, E.S. Karpova
CARDIOVASCULAR SAFETY AND EFFICACY OF CELECOXIB: FOCUS ON TREATMENT AND CARDIOSOMATIC REHABILITATION
|
№15 / 2017
|
I.A. Zolotovskaya (1), I.L. Davydkin (1), N.Yu. Borovkova (2)
THERAPY WITH NONSTEROID ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH ACUTE NONSPECIFIC LOW BACK PAIN: DYNAMICS OF RENAL FUNCTION: RESULTS OF “PANDA” COGORT STUDY
|
№7 / 2017
|
I.O. Smitienko (1), P.I. Novikov (2)
MODERN VIEW ON THE ANALGESIC DRUGS FOR OSTEOARTHRITIS: EVIDENCE FROM META-ANALYSIS ON THE EFFECTIVENESS
|
№19 / 2016
|
M.V. Leonova, E.E. Alimova, Yu.N. Eremina
DANGEROUS COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS, DIURETICS, AND NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN CLINICAL PRACTICE
|
№19 / 2016
|
E.S. Akarachkova (1), O.A. Gromova (2), O.V. Kotova (3)
SELECTION OF MODERN SAFE AND EFFECTIVE NSAID IN PATIENTS WITH CONCOMITANT (COMORBID) DISEASES
|
№7 / 2016
|